small molecule

DELSYM

DEXTROMETHORPHAN POLISTIREX

Loss of exclusivityloss of exclusivity
CompanyRB HEALTH US LLC

Drug detail

Brand nameDELSYM
Active ingredientDEXTROMETHORPHAN POLISTIREX
StrengthEQ 30MG HYDROBROMIDE/5ML
Dosage formSUSPENSION, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalOctober 1982
Marketing statusOTC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

DELSYM patent cliff — loss of exclusivity — | CliffBio